Try Alerts Free   |   Login

Ibio Financials and Smart Investor 13F Alerts

IBIO Sector: Health Care, Pharmaceutical Preparations

Data imported from SEC filings and provided as-is without any warranty. Check Ibio Inc filings before making any investment decision.

IBIO stock chart compared to Revenue:

IBIO Income Statement

Revenue, Net:1120000
Research and Development Expense:349000
Total Operating Expenses:4049000
Operating Income:-2929000
Income Taxes:null
Net Income (Loss) Attributable to Parent:-3538000
Earnings Per Share, Diluted:0.35
Earnings Per Share, Basic:0.35
Weighted Average Number of Shares Outstanding, Basic:180287751
Weighted Average Number of Shares Outstanding, Diluted:62795000

IBIO Cash Flow

Change in Accounts Receiveable:0
Net Cash from Operations:-3867000
Net Cash from Investing Activities:-820000
Net Change in Cash and Cash Equivalents:45072000

IBIO Balance Sheet

Cash and Cash Equivalents:55112000
Accounts Receivable, Net:75000
Total Current Assets:61748000
Property, Plant and Equipment, Net:3657000
Total Assets:94189000
Accounts Payable:1759000
Total Short-Term Liabilities:5236000
Total Liabilities:37582000